Dr. Brian Rash received his PhD in neuroscience from the University of Chicago in 2007 and completed postdoctoral and early faculty positions at Yale University, and throughout this career trajectory has studied neuroscience, cognitive neural development, stem cells, mitochondria, and the molecular cell biology and genetics of disease.  While in academia, Dr. Rash studied brain development and function, including developmental diseases of the brain and central nervous system. He continued to advance stem cell technology in biotech (Herophilus; San Francisco) and develop brain organoids at scale, leading efforts to discover small molecules in the treatment of Rett syndrome and Alzheimer’s disease.

Working at Longeveron (Miami, FL) as VP of Research and Discovery, Dr. Rash is advancing research and clinical trial efforts to develop treatments for a variety of conditions with their clinical stage IND, laromestrocel (Lomecel-BTM), a stem cell therapy with anti-inflammatory and pro-vascular therapeutic potential.  Dr. Rash is lead author of a recent study of laromestrocel in the treatment of mild Alzheimer’s disease, published in Nature Medicine, which showed safety and potential efficacy in slowing disease progression, and is working to further the human healthspan through the usage of new stem cell technologies.